Triptolide-containing formulation in patients with autosomal dominant polycystic kidney disease and proteinuria: an uncontrolled trial

Am J Kidney Dis. 2014 Jun;63(6):1070-2. doi: 10.1053/j.ajkd.2014.01.418. Epub 2014 Feb 20.

Authors

Dongping Chen¹, Yiyi Ma¹, Xueqi Wang¹, Shengqiang Yu¹, Lin Li¹, Bing Dai¹, Zhiguo Mao¹, Hongchao Liu¹, Shiyuan Liu¹, Changlin Mei²

Affiliations

¹ Shanghai Changzheng Hospital, Second Military Medical University, Shanghai, China.
² Shanghai Changzheng Hospital, Second Military Medical University, Shanghai, China. Electronic address: chlmei1954@126.com.

PMID: 24560027
DOI: 10.1053/j.ajkd.2014.01.418

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Adult
Diterpenes / administration & dosage*
Epoxy Compounds / administration & dosage
Female
Humans
Male
Medicine, East Asian Traditional
Middle Aged
Phenanthrenes / administration & dosage*
Phytotherapy*
Polycystic Kidney, Autosomal Dominant / complications*
Polycystic Kidney, Autosomal Dominant / drug therapy*
Proteinuria / complications*
Proteinuria / drug therapy
Treatment Outcome
Tripterygium*

Substances

Diterpenes
Epoxy Compounds
Phenanthrenes
triptolide